The North American infusion therapy devices market is projected to witness a considerable growth rate by exhibiting a significant CAGR of 5.0% during the forecast period. The market growth is driven by the increasing aging population and the rising incidence of chronic diseases such as diabetes, cancer, and others. Moreover, the rising number of surgeries performed in hospitals and ambulatory care settings, rising demand for diabetes management devices are contributing to the market growth in North America. The prevalence of diabetes is increasing in the region which is a major factor making a shift for the need for the infusion pump. According to IDF, the prevalence of diabetes is around 13.3% of the total adult population in the region which is expected to increase up to 14.2% by 2030 and 15% by 2045. In numbers, it is around 47.6 million in 2019 which is expected to augment 56 million by 2030.

Visit for Global Infusion Therapy Devices Market Report at: https://www.omrglobal.com/industry-reports/infusion-therapy-devices-market-size

The North American infusion therapy devices market is segmented on the basis of product type, application, and end-user. Based on the product type, the market is classified into infusion pumps and consumables & accessories. Based on the application, the market is segregated into oncology, diabetes, gastroenterology, analgesia, hematology, and others. The end-user segment is classified into hospitals, home care, and ambulatory surgery centers.

The major players contributing to the growth of the North American infusion therapy devices market include B. Braun Melsungen AG, Becton, Dickinson, and Co., Infuserve America Inc., Ivenix, Inc., Medtronic PLC, Moog Inc., Novartis AG, and Terumo Corp. The players operating in the market adopt various strategies such as technology development, product launch, merger and acquisitions for gaining a sustainable position in the market that further propels the growth of the market. For instance, in May 2018, Baxter International, Inc. received an FDA approval for Spectrum IQ Infusion System with Dose IQ safety software. With this approval, the company will be able to commercialize and sell their products that will further increase their revenue in the market.   

Research Methodology

The market study of the North American infusion therapy device market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. The numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to get first-hand information. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market
• Authentic public databases such as the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Cancer Society (ACS), National Institutes of Health (NIH), American Heart Association (AHA), and International Diabetes Federation (IDF).
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog

The report is intended for infusion therapy device market players, potential entrants, medical device companies, healthcare providers, investment companies, research institutes, universities, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

1. North American Infusion Therapy Devices Market Research and Analysis by Product Type.

2. North American Infusion Therapy Devices Market Research and Analysis by End-User. 

3. North American Infusion Therapy Devices Market Research and Analysis by Application.

The Report Covers

• Comprehensive research methodology of the North American infusion therapy devices market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American infusion therapy devices market.
• Insights about market determinants which are stimulating the North American infusion therapy devices market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.